Bipin B. Bhakta, Rory J. O’Connor1 and J. Alastair Cozens
DOI: 10.2340/16501977-0120

Objective: To measure the impact of botulinum toxin A on associated reactions in patients following stroke.
Design: Randomized placebo-controlled trial.
Patients: Forty patients with spasticity in their paretic arm (median time since stroke: 2. 7 years) were randomized to botulinum toxin A (Dysport® 1000 mouse units (MU) divi­ded between elbow, wrist and finger flexors) or placebo.
Methods: Associated reactions were measured using hand dynamometry. The effort used was measured using maximum voluntary grip in the unaffected arm. Measurements were recorded at 2 pre-treatment and 3 post-intervention times. Activities that patients felt caused associated reactions and activities that were affected by associated reactions were recorded.
Results: Peak associated reactions force was reduced at week 6 with botulinum toxin A compared with placebo (mean group difference 19. 0 N; 95% confidence interval (CI): 7. 2, 30. 9; p < 0. 01) and week 2 (p = 0. 005), with the effect wearing off by week 12 (p = 0. 09). Thirty-one patients noted associated reactions on a regular basis and 24 said that these movements interfered with daily activities. Ten of 12 patients receiving botulinum toxin A and 2 of 12 receiving placebo reported reduction in interference with daily activities (p = 0. 02).
Conclusion: Botulinum toxin A reduces associated reactions and may be a useful adjunct to other rehabilitation interventions. The impact of associated reactions on daily activities may also be reduced.